Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "New Drug Approvals and Their Contract Manufacture - 2024 Edition" report has been added to ResearchAndMarkets.com's offering.
This report is the 14th edition of the long-running analysis of the CMO industry, using the FDA's NDA approvals as the primary indicator of performance. The report is critical for benchmarking the performance of the contract manufacturing organization (CMO) industry and the relative performance of major CMOs. This year's edition includes a discussion of how inflation and increasing global conflict has impacted pharma manufacturers.
Report Scope:
- Overview of NDA drug and vaccine approvals and the levels of outsourcing associated with NDA sub segments
- Detailed view of CDMO performance by number of drug and vaccine approvals
- An assessment of pharmaceutical companies' propensity to outsource manufacture, by their market caps, based on the analyst's Contract Service Providers database
- Outsourcing propensity for New Molecular Entities (NMEs), different dosage forms, and other drug attributes.
- Analysis of NME special product approvals such as those with Accelerated Approval, Orphan, Breakthrough or Fast Track designations and assessment of outsourcing
This report gives important, expert insight you won't find in any other source. 18 tables and 25 figures throughout the report illustrate major points and trends.
This report is required reading for:
- CMO executives who must have deep understanding of drug approvals and outsourcing to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Key Topics Covered:
- Executive Summary
- Players
- Technology Briefing
- Innovative drug approvals
- Dose outsourcing of drug approvals
- Trends
- Industry Analysis
- Introduction
- FDA NDA approvals overview
- Cell and gene therapies
- First-in-class
- First-time approvals
- Predicted drug events for 2024
- Sponsor trends
- FDA: outsourced dose manufacture
- Dosage form outsourcing
- Special product categories
- Accelerated approvals
- Orphan drug designation
- Fast track designation
- Breakthrough therapy designation
- Containment
- CMO performance
- Dosage form
- Outsourced API approvals
- ANDA approvals
- What it means
- FDA approvals hit a record high, recovering from a slump in 2022
- Opportunities for injectable manufacturers
- Catalent acquisition shakes up both the pharma and CMO landscape
- Record ATMP approvals and gene therapy firsts
- First topical gene therapy
- First CRISPR approval
- Cell and gene therapy current limitations
- A few large CMOs gain majority of dose contracts
- Increasing global conflict
- The future of manufacturing: AI, ESG, drug shortages, and personalized medicines
- Value Chain
- Companies
A selection of companies mentioned in this report includes:
- AbbVie Inc
- ACS Dobfar SpA
- AdhexPharma
- Aenova Holding GmbH
- Afton Scientific Corp
- AGC Biologics Inc
- Ajinomoto Bio-Pharma Services
- Akorn Operating Company LLC
- Alcami Corp
- Alfasigma SpA
- Allergopharma GmbH & Co KG
- Almac Group Ltd
- Alpex Pharma SA
- Altasciences Co Inc
- AqVida GmbH
- Arx LLC
- ASM Aerosol-Service AG
- AstraZeneca Plc
- AtomVie Global Radiopharma Inc
- Aurobindo Pharma Ltd
- AustarPharma LLC
- Avara Pharmaceutical Services Inc
- Baccinex SA
- Basic Pharma
- Bausch & Lomb Pharmaceuticals Inc
- Bayer AG
- Berkshire Sterile Manufacturing LLC
- Biogen Inc
- BioRamo LLC
- BioReliance Corp
- Boehringer Ingelheim Biopharmaceuticals GmbH
- Boehringer Ingelheim RCV GmbH & Co KG
- Bora Pharmaceuticals Co Ltd
- Bristol-Myers Squibb Co
- BSP Pharmaceuticals SpA
- Bushu Pharmaceuticals Ltd
- Cambrex Corp
- Catalent Inc
- Cenexi SAS
- Cerovene Inc
- Chia Tai Tianqing Pharmaceutical Group Co Ltd
- Contract Pharmaceuticals Ltd
- Corden Pharma International GmbH
- CoreRx Inc
- Corium Innovations Inc
- Curia Global Inc
- Delpharm SAS
- Dexcel PT Israel Ltd
- DPT Laboratories Ltd
- Eisai Co Ltd
- EMD Serono Inc
- Emergent BioSolutions Inc
- EuroAPI SAS
- Eurofins Scientific SE
- Excella GmbH & Co KG
- Exela Pharma Sciences LLC
- Exelead Inc
- Fareva SA
- Ferndale Pharma Group Inc
- Fidia farmaceutici SpA
- FinVector Oy
- Fresenius Kabi AG
- Fritz Keller Holding AG
- Fuji Yakuhin Co Ltd
- FUJIFILM Diosynth Biotechnologies USA Inc
- Gensenta Ilac Sanayi ve Ticaret AS
- Gland Pharma Ltd
- Glatt GmbH
- Grifols SA
- Groupe Parima Inc
- Grunenthal GmbH
- Hanford Pharmaceuticals
- Hetero Drugs Ltd
- Hikma Pharmaceuticals Plc
- Holopack Verpackungstechnik GmbH
- Hovione FarmaCiencia SA
- IDT Biologika GmbH
- Importfab Inc
- Ipsen SA
- Iwaki Seiyaku Sakura Factory Co Ltd
- James Alexander Corp
- Jubilant HollisterStier LLC
- Juzen Chemical Corp
- Kyowa Hakko Bio Co Ltd
- Laboratorios Farmaceuticos Rovi SA
- Lek Pharmaceuticals dd
- LGM Pharma LLC
- Lichtenheldt GmbH
- Lifecore Biomedical LLC
- Lonza Group Ltd
- LTS Lohmann Therapie-Systeme AG
- Lupin Ltd
- Mawdsley-Brooks & Co Ltd
- MIAS Pharma Ltd
- Mibe GmbH Arzneimittel
- Mikart LLC
- Minaris Regenerative Medicine LLC
- Mipharm SpA
- Mission Pharmacal Co
- Molteni Farmaceutici
- National Resilience Inc
- Neolpharma SA De CV
- NerPharma Srl
- NextPharma Technologies Holding Ltd
- Nova Laboratories Ltd
- Novartis AG
- Novast Holdings Ltd
- NUVISAN Pharma Holding GmbH
- OishiKoseido Corp
- Oncotec Pharma Produktion GmbH
- Organon & Co
- PARI Pharma GmbH
- PCI Pharma Services
- Pfizer Inc
- Pharmaceutics International Inc
- Pharmasol Corp
- Pharmathen Global BV
- Pharmstandard
- Pierrel SpA
- Piramal Pharma Solutions Inc
- Polymun Scientific Immunbiologische Forschung GmbH
- Procaps SAS
- PYRAMID Laboratories Inc
- Qilu Pharmaceutical Co Ltd
- QPS Holdings LLC
- Quotient Sciences Ltd
- Rechon Life Science AB
- Recipharm AB
- Renaissance Lakewood LLC
- Rentschler Biopharma SE
- Rivopharm SA
- Rottendorf Pharma GmbH
- R-Pharm
- Samsung Biologics Co Ltd
- Sandoz International GmbH
- Sanico NV
- Sanofi
- Sawai Pharmaceutical Co Ltd
- Sever Pharma Solutions AB
- SGS Quay Pharmaceuticals Ltd
- Sharp Packaging Services
- Sichuan Huiyu Pharmaceutical Co Ltd
- Siegfried Holding AG
- Simtra BioPharma Solutions
- Sintetica SA
- Sirton Pharmaceuticals SpA
- Skyepharma Production SAS
- SM Farmaceutici Srl
- Stada Arzneimittel AG
- Steri-Pharma LLC
- Takeda Pharmaceutical Co Ltd
- Tapemark Co
- Teikoku Seiyaku Co Ltd
- Teligent Inc
- The Biovac Institute
- The Ritedose Corp
- Thermo Fisher Scientific Inc
- TOYO Pharmaceutical Co Ltd
- Toyobo Co Ltd
- Tulex Pharmaceuticals Inc
- Unither Pharmaceuticals SAS
- UPM Pharmaceuticals Inc
- Vetter Pharma-Fertigung GmbH & Co KG
- Vianex SA
- Woodstock Sterile Solutions
- WuXi Biologics Cayman Inc
- WuXi XDC Cayman Inc
- Xellia Pharmaceuticals ApS
- Zydus Lifesciences Ltd
For more information about this report visit https://www.researchandmarkets.com/r/hkobxe
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
